Navigation Links
Endologix Reports 22% Second Quarter 2011 Revenue Growth
Date:7/21/2011

General and administrative3,3242,2136,9034,284Total operating expenses20,20212,22939,20223,552Loss from operations$

(5,177)$

(187)$

(10,002)$

(391)Other income/(expense)Other income/(expense)111(193)141(214)Change in fair value of contingent consideration related to acquisition(8,600)—(8,600)—Total other income/(expense)(8,489)(193)(8,459)(214)Net loss(13,666)(380)(18,461)(605)Basic and diluted net loss per share(0.24)(0.01)(0.33)(0.01)Shares used in computing basic and diluted net loss per share56,21748,32556,06248,160Non-GAAP Reconciliation –Net Loss to Adjusted Net Loss and Adjusted Net Loss per Share:Net loss$

(13,666)$

(380)$

(18,461)$

(605)Fair value adjustment to the liability for contingent payments to the former Nellix shareholders (non-cash)8,600—8,600—Adjusted net loss$

(5,066)$

(380)$

(9,861)$

(605)Adjusted net loss per share$

(0.09)$

(0.01)$

(0.18)$

(0.01)ENDOLOGIX, INC.CONDENSED CONSOLIDATED BALANCE SHEETSUnaudited(In thousands)June 30,December 31,20112010ASSETSCurrent assets:Cash and cash equivalents$

30,865$

38,191Accounts receivable, net12,56012,212Other receivables379515Inventories13,5688,350Other current assets846560Total current assets58,21859,828Property and equipment, net2,6682,429Goodwill27,07327,073Intangibles, net44,15144,863Other assets187182Total Assets$

132,297$

134,375LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable and accrued expenses$

13,525$

11,243Current liabilities13,52511,243Long term liabilities:Other long term liabilities1,0461,029Contingently issuable common stock36,80028,200Long term liabilities37,84629,229Total liabilities51,37140,472Stockholders' equity:Common stock, $.001 par value; 75,000 shares authorized, and 57,760 and 56,896 shares issued, and 57,265 and 56,401 outstanding5857Additional paid-in capital235,500230,01
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FOREST, Ill. , March 6, 2015   Hospira, ... the U.S. Food and Drug Administration (FDA) on today,s FDA ... States . This is a watershed moment for improving ... As a leading global provider of biosimilars, Hospira has seen ... we are a proud participant in these early stages of ...
(Date:3/6/2015)... -- Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... at the 27th Annual ROTH Conference on March 10, ... scheduled to present at 5:30 pm Pacific on March ... The Ritz-Carlton Hotel in Laguna Niguel, California ...
(Date:3/6/2015)... , March 6, 2015 Troyen A. ... Officer of CVS Health (NYSE: CVS ), ... in Washington, D.C. today.  Brennan ... role in addressing health care cost and quality as ... making CVS/pharmacy the first national pharmacy chain to stop ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3
... , March 23 The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) ... ... ... ...
... medical device companies, today announced it has been selected by the Advanced Medical Technology Association (AdvaMed), as a member of the organization,s Business Solutions Program. , ... , ... ... ...
Cached Medicine Technology:Novalung Records 50% Growth 2Novalung Records 50% Growth 3AdvaMed Selects Prolifiq as Member of Business Solutions Program 2AdvaMed Selects Prolifiq as Member of Business Solutions Program 3AdvaMed Selects Prolifiq as Member of Business Solutions Program 4
(Date:3/6/2015)... CHICAGO (PRWEB) March 06, 2015 As ... and healthcare services programs, the organization has hired two ... Hagerty, Ph.D. They will report to Grace Pavlath, ... Vice President and Scientific Program Director, and together will ... lead to treatments and cures for various types of ...
(Date:3/6/2015)... Parents need to start the discourse ... use disorders. School programs like DARE, or Drug Abuse ... or Narcotics Overdose Prevention and Education has already impacted ... News on Feb. 27th. As teens continue to ... drug prevention proponents are lobbying Florida to pass The ...
(Date:3/6/2015)... Anaheim, Cailfornia (PRWEB) March 06, 2015 ... lifestyle technology company, announced today the launch of ... save money on healthy and sustainable products at ... retailers. Makeena is exhibiting at Expo West Booth ... to search by gluten-free, Kosher, non-GMO, organic, Paleo, ...
(Date:3/6/2015)... 06, 2015 Since Medicare began paying ... there has been an overwhelming demand from providers for ... compliant CCM program. The Centers for Medicare & ... , PYA’s updated white paper—“ Providing and Billing ... into a detailed, yet practical “how to” manual for ...
(Date:3/6/2015)... Atlanta, GA (PRWEB) March 06, 2015 ... algorithms, announced the release of a Clostridium Difficile ... outpatient providers. The C Diff use case is ... capabilities that span hospital acquired infections, chronic conditions, ... phenotype platform, the C Diff solution flags at ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... The bottom-line message from a decades-long study of monkeys ... leads to a longer, healthier life. Writing today ... team of researchers at the University of Wisconsin-Madison, the ... Middleton Memorial Veterans Hospital reports that a nutritious but ...
... July 9 Connectyx (Other OTC: CTYX) - Connectyx Technologies ... hosting a Nationwide Teleconference today, July 9, 2009, at 4:15pm ... Schuman, Connectyx President and CEO will update shareholders and the ... Company has developed over the last six months, its initiatives ...
... 9 Emergency information is just one touch away with ... application for the Apple iPhone. , , This is ... to review first aid procedures, anytime, anywhere. First aid instructions ... , Powered by Jive Media, the application is available for ...
... Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), ... tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring ... M.D., Chairman and Chief Executive Officer, will present at the ... 5:30 pm ET. The presentation will occur live and ...
... to grow in popularity, injuries to soccer players are ... into gender-based patterns and new research at Hospital for ... lead to better treatment, or even prevention for present ... year,s American Orthopaedic Society for Sports Medicine meeting in ...
... Ga., July 9 Immucor, Inc. (Nasdaq: BLUD ... the blood transfusion industry, today announced that it will release ... after the market close. The Company will host a conference ... time) to discuss the results. , , ...
Cached Medicine News:Health News:Reduced diet thwarts aging, disease in monkeys 2Health News:Reduced diet thwarts aging, disease in monkeys 3Health News:Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results 2Health News:American Heart Association Launches First iPhone Application: First Aid and CPR Information Within Pocket's Reach 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 3Health News:Motion analysis helps soccer players get their kicks 2Health News:Motion analysis helps soccer players get their kicks 3
... Chrono-log's wide range of Platelet aggregometers ... to meet particular needs. Single, dual ... with chart recorder outputs or digital ... Chrono-log Optical aggregometers, which measure platelet ...
... a four channel platelet aggregation profiler combined ... in conjunction with Microsoft WindowsTM, the PAP-4CD ... tests, automatic storage of test results, plus ... test modes are available: chromogenic assays, von ...
... is a four channel platelet aggregation profiler ... assays, von Willebrand assay (Ristocetin cofactor), platelet ... also be used for the evaluation and ... channels allow four tests to be run ...
... plus, innovation means 4 on-board measurement ... and im-proved operator ergonomics. This supports ... required for true workload consolidation, leading ... only one analytical platform, one user ...
Medicine Products: